NASAL

NASAL was reported 31601 times

NASAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOCARDIAL REPERFUSION INJURY 6 0.1579
1 MYOTONIC DYSTROPHY 5 0.0641
2 GASTROINTESTINAL STOMA OUTPUT DECREASED 5 0.0355
3 NAIL BED INFLAMMATION 8 0.0251
4 TETANY 45 0.0247
5 RAPID CORRECTION OF HYPONATRAEMIA 6 0.0239
6 GASTROINTESTINAL STOMA OUTPUT INCREASED 9 0.0192
7 MENINGITIS CHEMICAL 4 0.0182
8 MATERNAL EXPOSURE DURING DELIVERY 18 0.0182
9 BRACHIAL PLEXOPATHY 4 0.0181
10 PNEUMONITIS ASPIRATION 5 0.0146
11 NASAL MUCOSAL DISORDER 8 0.0137
12 GASTRIC MUCOSA ERYTHEMA 4 0.0121
13 RADIOISOTOPE SCAN ABNORMAL 8 0.0113
14 CAUDA EQUINA SYNDROME 8 0.0104
15 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 11 0.0104
16 STOMA COMPLICATION 10 0.0098
17 STREPTOCOCCAL SEPSIS 10 0.0084
18 OSMOTIC DEMYELINATION SYNDROME 5 0.0068
19 VASCULAR DEVICE INFECTION 30 0.0066
20 PSEUDOMONAL SEPSIS 11 0.0063
21 NEPHROGENIC DIABETES INSIPIDUS 7 0.0061
22 HYPORESPONSIVE TO STIMULI 7 0.0060
23 MARROW HYPERPLASIA 4 0.0059
24 FACIAL DISCOMFORT 4 0.0056
25 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 18 0.0054
26 EXCESSIVE GRANULATION TISSUE 4 0.0050
27 EXCESSIVE EYE BLINKING 7 0.0047
28 ENDOCRINE OPHTHALMOPATHY 4 0.0046
29 CANDIDA SEPSIS 4 0.0045
30 CARBON DIOXIDE DECREASED 5 0.0043
31 CEREBROSPINAL FLUID LEAKAGE 8 0.0043
32 STAPHYLOCOCCUS TEST POSITIVE 9 0.0043
33 PROCALCITONIN INCREASED 5 0.0043
34 MICROANGIOPATHY 4 0.0043
35 COLON NEOPLASM 4 0.0041
36 BLOOD CHLORIDE INCREASED 7 0.0040
37 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 5 0.0040
38 HYPERNATRAEMIA 20 0.0040
39 ADMINISTRATION SITE EXTRAVASATION 4 0.0040
40 KOUNIS SYNDROME 9 0.0040
41 BRONCHIAL SECRETION RETENTION 5 0.0039
42 VENTRICULAR ARRHYTHMIA 14 0.0038
43 GASTROINTESTINAL STOMA COMPLICATION 6 0.0038
44 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
45 INCORRECT DRUG ADMINISTRATION RATE 16 0.0038
46 ANION GAP INCREASED 5 0.0037
47 GALLBLADDER ENLARGEMENT 4 0.0037
48 INFUSION SITE MASS 4 0.0037
49 DEVICE INFUSION ISSUE 9 0.0036
50 AUDITORY DISORDER 5 0.0035
51 SPINAL CORD INJURY 6 0.0034
52 INFUSION SITE DISCHARGE 6 0.0034
53 INFUSION SITE HAEMORRHAGE 11 0.0033
54 INFECTED CYST 4 0.0033
55 HYPOSMIA 5 0.0033
56 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18 0.0033
57 SPUTUM INCREASED 7 0.0032
58 JAUNDICE NEONATAL 6 0.0032
59 DRUG CLEARANCE DECREASED 4 0.0031
60 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 8 0.0031
61 BILIRUBIN CONJUGATED INCREASED 7 0.0030
62 ESCHERICHIA BACTERAEMIA 7 0.0030
63 INFUSION SITE EXTRAVASATION 18 0.0029
64 PULMONARY FUNCTION TEST DECREASED 12 0.0027
65 PALLOR 74 0.0027
66 MYASTHENIA GRAVIS CRISIS 4 0.0027
67 BLOOD SODIUM INCREASED 7 0.0026
68 BRAIN DEATH 8 0.0026
69 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
70 MULTIPLE ALLERGIES 20 0.0025
71 HYPERAEMIA 5 0.0025
72 SINUS OPERATION 6 0.0025
73 OBSTRUCTION 10 0.0025
74 CAPILLARY LEAK SYNDROME 5 0.0024
75 CATHETER SITE HAEMORRHAGE 6 0.0024
76 PROTEIN TOTAL DECREASED 9 0.0024
77 RHINOVIRUS INFECTION 9 0.0023
78 ACTINIC KERATOSIS 6 0.0023
79 EPIGASTRIC DISCOMFORT 9 0.0023
80 RESPIRATORY ACIDOSIS 9 0.0023
81 AORTIC VALVE STENOSIS 4 0.0022
82 INFUSION SITE PRURITUS 7 0.0022
83 BILE DUCT STONE 7 0.0022
84 BLOOD PRESSURE SYSTOLIC DECREASED 10 0.0022
85 CYSTIC FIBROSIS 12 0.0022
86 VARICOSE VEIN 11 0.0021
87 CONTRAST MEDIA REACTION 5 0.0021
88 PARAESTHESIA ORAL 30 0.0021
89 HEPATIC MASS 4 0.0021
90 HYPERVOLAEMIA 10 0.0020
91 ENDOPHTHALMITIS 12 0.0020
92 HYPERCAPNIA 6 0.0020
93 CRANIOCEREBRAL INJURY 6 0.0020
94 BUNDLE BRANCH BLOCK RIGHT 9 0.0020
95 CHANGE OF BOWEL HABIT 4 0.0019
96 METASTASES TO LYMPH NODES 13 0.0019
97 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 17 0.0019
98 INFUSION SITE SWELLING 12 0.0019
99 PNEUMONIA VIRAL 6 0.0019
100 MYCOBACTERIUM AVIUM COMPLEX INFECTION 5 0.0019
101 NORMAL NEWBORN 10 0.0018
102 DEAFNESS NEUROSENSORY 6 0.0018
103 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 6 0.0018
104 OLIGOHYDRAMNIOS 6 0.0018
105 HYPERCALCAEMIA 22 0.0018
106 FORCED EXPIRATORY VOLUME DECREASED 5 0.0018
107 SKIN NECROSIS 9 0.0017
108 HYPERREFLEXIA 6 0.0017
109 ACUTE RESPIRATORY FAILURE 33 0.0017
110 PULMONARY PAIN 5 0.0017
111 HYPOVOLAEMIA 10 0.0017
112 HYPOXIA 60 0.0017
113 DEPRESSIVE SYMPTOM 6 0.0017
114 PULSELESS ELECTRICAL ACTIVITY 7 0.0017
115 DIABETES INSIPIDUS 4 0.0017
116 CANDIDA INFECTION 28 0.0017
117 LYMPHADENITIS 4 0.0017
118 CYTOKINE RELEASE SYNDROME 33 0.0016
119 BLOOD PHOSPHORUS DECREASED 6 0.0016
120 DYSCHEZIA 5 0.0016
121 MASTICATION DISORDER 5 0.0016
122 HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.0016
123 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
124 OLIGURIA 10 0.0016
125 INFREQUENT BOWEL MOVEMENTS 4 0.0016
126 CHRONIC SINUSITIS 6 0.0016
127 PARONYCHIA 7 0.0016
128 CANCER PAIN 4 0.0016
129 BLOOD CHLORIDE DECREASED 4 0.0015
130 TACHYPNOEA 21 0.0015
131 COMPARTMENT SYNDROME 4 0.0015
132 CARDIOGENIC SHOCK 22 0.0015
133 HYPERSENSITIVITY VASCULITIS 4 0.0015
134 ARTHRITIS INFECTIVE 7 0.0015
135 APPETITE DISORDER 10 0.0015
136 BLOOD MAGNESIUM DECREASED 13 0.0015
137 BRAIN OEDEMA 19 0.0015
138 AREFLEXIA 4 0.0015
139 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
140 CLONUS 4 0.0015
141 RESPIRATORY TRACT INFECTION 38 0.0015
142 ATELECTASIS 14 0.0014
143 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
144 GRANULOMA 5 0.0014
145 NASAL DRYNESS 9 0.0014
146 ANAL HAEMORRHAGE 4 0.0014
147 PRODUCTIVE COUGH 68 0.0014
148 DRUG TOLERANCE DECREASED 4 0.0014
149 BRONCHIOLITIS 5 0.0014
150 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 24 0.0014
151 SEASONAL ALLERGY 20 0.0014
152 TORSADE DE POINTES 11 0.0014
153 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
154 UNRESPONSIVE TO STIMULI 36 0.0014
155 ERYSIPELAS 7 0.0014
156 LOW BIRTH WEIGHT BABY 11 0.0014
157 URINE OUTPUT DECREASED 12 0.0014
158 ASTHMATIC CRISIS 5 0.0014
159 FOOD INTOLERANCE 5 0.0014
160 TUMOUR LYSIS SYNDROME 12 0.0014
161 COLD SWEAT 24 0.0014
162 SECRETION DISCHARGE 17 0.0014
163 BLOOD CREATINE INCREASED 6 0.0014
164 POOR VENOUS ACCESS 14 0.0014
165 WHEELCHAIR USER 6 0.0013
166 FEELING HOT 82 0.0013
167 CYANOSIS 21 0.0013
168 HYPOAESTHESIA ORAL 20 0.0013
169 PARANASAL SINUS DISCOMFORT 5 0.0013
170 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
171 HYPOTONIA 13 0.0013
172 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
173 NEPHROGENIC ANAEMIA 6 0.0013
174 HYPOALBUMINAEMIA 10 0.0013
175 PSEUDOMONAS INFECTION 11 0.0013
176 FLANK PAIN 12 0.0013
177 ORAL INFECTION 5 0.0013
178 WHEEZING 75 0.0013
179 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
180 BLOOD ALBUMIN DECREASED 10 0.0013
181 OBSTRUCTIVE AIRWAYS DISORDER 14 0.0013
182 BLOOD CALCIUM DECREASED 14 0.0012
183 MYOCARDIAL ISCHAEMIA 14 0.0012
184 DECUBITUS ULCER 10 0.0012
185 POLYURIA 10 0.0012
186 PRODUCT PREPARATION ISSUE 8 0.0012
187 RALES 7 0.0012
188 NEPHRITIS 4 0.0012
189 PREMATURE DELIVERY 19 0.0012
190 UROSEPSIS 11 0.0012
191 BRONCHIECTASIS 8 0.0012
192 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 7 0.0012
193 BOWEL MOVEMENT IRREGULARITY 9 0.0012
194 DRUG TOXICITY 16 0.0012
195 HYPOKALAEMIA 54 0.0012
196 SINUS DISORDER 23 0.0012
197 LEUKOCYTOSIS 21 0.0012
198 JOINT EFFUSION 8 0.0012
199 APNOEA 9 0.0012
200 NO THERAPEUTIC RESPONSE 14 0.0011
201 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
202 WEIGHT FLUCTUATION 12 0.0011
203 EAR PRURITUS 4 0.0011
204 NECROTISING FASCIITIS 4 0.0011
205 JAUNDICE CHOLESTATIC 4 0.0011
206 PHYSICAL DISABILITY 5 0.0011
207 SINUS TACHYCARDIA 16 0.0011
208 NEUTROPENIC SEPSIS 8 0.0011
209 IMPLANT SITE PAIN 5 0.0011
210 MENINGITIS ASEPTIC 5 0.0011
211 BLOOD BILIRUBIN INCREASED 30 0.0011
212 BONE LESION 4 0.0011
213 ABNORMAL FAECES 9 0.0011
214 HYPOTHERMIA 11 0.0011
215 OXYGEN SATURATION DECREASED 61 0.0011
216 VENTRICULAR FIBRILLATION 12 0.0011
217 PNEUMOTHORAX 17 0.0011
218 ACUTE PULMONARY OEDEMA 6 0.0011
219 YELLOW SKIN 5 0.0011
220 METABOLIC ACIDOSIS 34 0.0011
221 BLOOD SODIUM DECREASED 20 0.0011
222 CHOLECYSTITIS ACUTE 6 0.0011
223 PERONEAL NERVE PALSY 6 0.0011
224 RESPIRATORY DISTRESS 29 0.0010
225 COMMUNICATION DISORDER 4 0.0010
226 ATRIOVENTRICULAR BLOCK COMPLETE 7 0.0010
227 PNEUMONIA ASPIRATION 26 0.0010
228 INCONTINENCE 11 0.0010
229 ENTEROCOLITIS 6 0.0010
230 SINUS BRADYCARDIA 10 0.0010
231 HYPONATRAEMIA 58 0.0010
232 VENTRICULAR TACHYCARDIA 17 0.0010
233 EJECTION FRACTION DECREASED 16 0.0010
234 CARDIOPULMONARY FAILURE 4 0.0010
235 HEREDITARY ANGIOEDEMA 11 0.0010
236 PERIPHERAL COLDNESS 14 0.0010
237 BRADYCARDIA 54 0.0010
238 C-REACTIVE PROTEIN INCREASED 37 0.0010
239 STAPHYLOCOCCAL SEPSIS 5 0.0010
240 MUCOUS STOOLS 5 0.0010
241 HYPOAESTHESIA 151 0.0010
242 THIRST 18 0.0010
243 RENAL CYST 8 0.0010
244 ARTERIOSPASM CORONARY 4 0.0010
245 OROPHARYNGEAL DISCOMFORT 9 0.0010
246 KLEBSIELLA INFECTION 5 0.0010
247 FOETAL GROWTH RESTRICTION 6 0.0010
248 MOTOR DYSFUNCTION 10 0.0010
249 INSURANCE ISSUE 15 0.0010
250 PNEUMONIA BACTERIAL 9 0.0010
251 SLUGGISHNESS 10 0.0010
252 AMMONIA INCREASED 5 0.0010
253 NEPHROPATHY TOXIC 11 0.0010
254 NEUTROPHIL COUNT INCREASED 10 0.0010
255 EAR DISCOMFORT 10 0.0010
256 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
257 EXTRAVASATION 4 0.0010
258 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
259 LEG AMPUTATION 4 0.0010
260 PARAESTHESIA 152 0.0010
261 HYPERBILIRUBINAEMIA 10 0.0010
262 HEPATIC ENCEPHALOPATHY 9 0.0010
263 PREMATURE BABY 29 0.0010
264 FAILURE TO THRIVE 5 0.0010
265 PAIN IN JAW 27 0.0010
266 SPINAL DISORDER 9 0.0009
267 SERUM FERRITIN INCREASED 5 0.0009
268 HYPOPHOSPHATAEMIA 7 0.0009
269 RESPIRATORY TRACT CONGESTION 15 0.0009
270 ABSCESS LIMB 4 0.0009
271 SNEEZING 21 0.0009
272 INFUSION SITE PAIN 12 0.0009
273 ANAL ABSCESS 5 0.0009
274 GINGIVITIS 5 0.0009
275 TROPONIN INCREASED 7 0.0009
276 ACIDOSIS 7 0.0009
277 DIVERTICULUM INTESTINAL 4 0.0009
278 ASPIRATION 10 0.0009
279 SPINAL OSTEOARTHRITIS 8 0.0009
280 STAPHYLOCOCCAL INFECTION 30 0.0009
281 CARDIAC ARREST 75 0.0009
282 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
283 RESPIRATORY DISORDER 27 0.0009
284 CHOLECYSTITIS CHRONIC 6 0.0009
285 HAEMOPTYSIS 25 0.0009
286 SMALL INTESTINAL OBSTRUCTION 11 0.0009
287 HAEMARTHROSIS 8 0.0009
288 POSTOPERATIVE WOUND INFECTION 6 0.0009
289 SINUS CONGESTION 12 0.0009
290 DRY THROAT 9 0.0009
291 LOWER RESPIRATORY TRACT INFECTION 40 0.0009
292 DYSPNOEA EXERTIONAL 33 0.0009
293 HYPERTONIA 5 0.0009
294 ANGINA PECTORIS 25 0.0009
295 MIOSIS 7 0.0009
296 EXERCISE TOLERANCE DECREASED 5 0.0009
297 PETECHIAE 9 0.0009
298 HYPOMAGNESAEMIA 12 0.0009
299 STRESS CARDIOMYOPATHY 5 0.0009
300 HICCUPS 7 0.0009
301 LYMPHOCYTE COUNT DECREASED 15 0.0008
302 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
303 BLOOD UREA INCREASED 14 0.0008
304 ORAL CANDIDIASIS 11 0.0008
305 HYPOVOLAEMIC SHOCK 4 0.0008
306 DYSGEUSIA 62 0.0008
307 PULMONARY CONGESTION 11 0.0008
308 KIDNEY TRANSPLANT REJECTION 4 0.0008
309 FAECAL INCONTINENCE 4 0.0008
310 MENTAL STATUS CHANGES 23 0.0008
311 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
312 MOUTH HAEMORRHAGE 6 0.0008
313 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
314 ANURIA 7 0.0008
315 NASAL POLYPS 4 0.0008
316 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
317 MEDICAL DEVICE COMPLICATION 6 0.0008
318 BREATH SOUNDS ABNORMAL 4 0.0008
319 SINUSITIS 83 0.0008
320 PYELONEPHRITIS 7 0.0008
321 MUSCLE SPASMS 148 0.0008
322 UPPER RESPIRATORY TRACT INFECTION 37 0.0008
323 BRAIN INJURY 8 0.0008
324 ANAPHYLACTIC REACTION 44 0.0008
325 CHILLS 93 0.0008
326 RESPIRATORY RATE INCREASED 7 0.0008
327 POST PROCEDURAL COMPLICATION 15 0.0008
328 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0008
329 MOVEMENT DISORDER 25 0.0008
330 ELECTROCARDIOGRAM QT PROLONGED 28 0.0008
331 HYPOTENSION 156 0.0008
332 MUSCULOSKELETAL CHEST PAIN 12 0.0008
333 INCOHERENT 5 0.0008
334 CHEST DISCOMFORT 78 0.0008
335 BLOOD LACTIC ACID INCREASED 4 0.0008
336 PULMONARY OEDEMA 34 0.0008
337 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
338 HYPERHIDROSIS 97 0.0008
339 EAR INFECTION 20 0.0008
340 CARDIAC FAILURE ACUTE 5 0.0007
341 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
342 FOOD POISONING 4 0.0007
343 SENSORY LOSS 6 0.0007
344 RHINITIS 6 0.0007
345 ARTERIOSCLEROSIS 7 0.0007
346 CARDIO-RESPIRATORY ARREST 31 0.0007
347 MUSCLE TIGHTNESS 12 0.0007
348 SPUTUM DISCOLOURED 7 0.0007
349 OEDEMA 40 0.0007
350 BLOOD PRESSURE DECREASED 49 0.0007
351 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
352 ANAPHYLACTIC SHOCK 19 0.0007
353 EPISTAXIS 55 0.0007
354 HEAD DISCOMFORT 13 0.0007
355 ENCEPHALOPATHY 18 0.0007
356 JAW DISORDER 4 0.0007
357 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
358 LYMPHOEDEMA 5 0.0007
359 COAGULOPATHY 12 0.0007
360 EAR PAIN 14 0.0007
361 GASTROENTERITIS VIRAL 13 0.0007
362 APHONIA 10 0.0007
363 MASS 10 0.0007
364 MALNUTRITION 8 0.0007
365 HEPATOMEGALY 7 0.0007
366 INFUSION SITE ERYTHEMA 6 0.0007
367 INFUSION RELATED REACTION 47 0.0007
368 LUNG INFECTION 11 0.0007
369 PULMONARY TOXICITY 5 0.0007
370 BASAL CELL CARCINOMA 11 0.0007
371 THERMAL BURN 5 0.0007
372 GENERALISED ERYTHEMA 4 0.0007
373 BRONCHOSPASM 10 0.0007
374 LIMB INJURY 19 0.0007
375 BLOOD POTASSIUM DECREASED 21 0.0007
376 SKIN HYPERPIGMENTATION 6 0.0007
377 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
378 ARRHYTHMIA 33 0.0007
379 HYPERVENTILATION 4 0.0007
380 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
381 ELECTROLYTE IMBALANCE 8 0.0007
382 EYELID OEDEMA 8 0.0007
383 GASTROENTERITIS 10 0.0007
384 ALANINE AMINOTRANSFERASE INCREASED 42 0.0007
385 ORAL DISORDER 5 0.0007
386 COUGH 191 0.0007
387 FEBRILE NEUTROPENIA 45 0.0007
388 SENSITIVE SKIN 5 0.0007
389 BRADYKINESIA 4 0.0007
390 COVID-19 PNEUMONIA 8 0.0007
391 BLOOD POTASSIUM INCREASED 11 0.0007
392 VENTRICULAR EXTRASYSTOLES 7 0.0007
393 BLOOD CREATININE INCREASED 44 0.0007
394 SEPSIS 75 0.0007
395 TENDERNESS 7 0.0007
396 IMMUNODEFICIENCY 10 0.0007
397 MACULAR DEGENERATION 8 0.0007
398 FLUSHING 68 0.0007
399 ANAL INCONTINENCE 6 0.0007
400 SEPTIC SHOCK 29 0.0007
401 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
402 TACHYCARDIA 59 0.0007
403 GANGRENE 4 0.0007
404 ASTHMA 75 0.0007
405 JOINT DISLOCATION 7 0.0007
406 VIRAL INFECTION 22 0.0007
407 WRONG TECHNIQUE IN DRUG USAGE PROCESS 24 0.0007
408 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
409 INGUINAL HERNIA 4 0.0007
410 INFECTION 95 0.0007
411 RESTLESSNESS 24 0.0007
412 RESPIRATORY DEPRESSION 8 0.0007
413 FACE OEDEMA 11 0.0007
414 DEHYDRATION 87 0.0007
415 PROCEDURAL COMPLICATION 5 0.0007
416 LIVER FUNCTION TEST INCREASED 14 0.0007
417 FLUID RETENTION 33 0.0006
418 THYROID DISORDER 10 0.0006
419 ASCITES 19 0.0006
420 PLEURAL EFFUSION 39 0.0006
421 DYSKINESIA 26 0.0006
422 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
423 SKIN REACTION 9 0.0006
424 ABORTION INDUCED 6 0.0006
425 MULTI-ORGAN FAILURE 11 0.0006
426 GASTROINTESTINAL PAIN 7 0.0006
427 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
428 SEROTONIN SYNDROME 12 0.0006
429 PULMONARY HYPERTENSION 13 0.0006
430 THROAT IRRITATION 28 0.0006
431 FISTULA 7 0.0006
432 HYPERCHOLESTEROLAEMIA 6 0.0006
433 ASPARTATE AMINOTRANSFERASE INCREASED 33 0.0006
434 PNEUMONIA 201 0.0006
435 ACUTE KIDNEY INJURY 95 0.0006
436 RHINORRHOEA 40 0.0006
437 FRUSTRATION TOLERANCE DECREASED 5 0.0006
438 FLATULENCE 35 0.0006
439 RESPIRATORY FAILURE 45 0.0006
440 HERPES SIMPLEX 4 0.0006
441 DYSPNOEA 348 0.0006
442 DERMATITIS CONTACT 7 0.0006
443 SCAB 7 0.0006
444 PHARYNGEAL SWELLING 6 0.0006
445 KIDNEY INFECTION 12 0.0006
446 DECREASED IMMUNE RESPONSIVENESS 6 0.0006
447 DYSARTHRIA 23 0.0006
448 EATING DISORDER 13 0.0006
449 JOINT INJURY 13 0.0006
450 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
451 HYPERGLYCAEMIA 22 0.0006
452 MENSTRUAL DISORDER 5 0.0006
453 ACUTE CORONARY SYNDROME 5 0.0006
454 PYREXIA 207 0.0006
455 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
456 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
457 LETHARGY 34 0.0006
458 CIRCULATORY COLLAPSE 10 0.0006
459 HEPATIC CIRRHOSIS 11 0.0006
460 VITAMIN D DECREASED 5 0.0006
461 ECCHYMOSIS 4 0.0006
462 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
463 HYPOCALCAEMIA 11 0.0006
464 NASAL CONGESTION 34 0.0006
465 MUSCLE STRAIN 5 0.0006
466 LARGE INTESTINE POLYP 4 0.0006
467 URINARY INCONTINENCE 17 0.0006
468 NEUROTOXICITY 10 0.0006
469 OSTEOARTHRITIS 24 0.0006
470 LUNG INFILTRATION 5 0.0006
471 GENERALISED OEDEMA 7 0.0006
472 ATRIAL FIBRILLATION 55 0.0006
473 HAND FRACTURE 4 0.0006
474 SCIATICA 9 0.0006
475 HAEMORRHOIDS 11 0.0006
476 CHOKING 11 0.0006
477 MATERNAL EXPOSURE DURING PREGNANCY 50 0.0006
478 GALLBLADDER DISORDER 10 0.0006
479 DECREASED ACTIVITY 6 0.0006
480 FREQUENT BOWEL MOVEMENTS 15 0.0006
481 DISORIENTATION 22 0.0006
482 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
483 MUSCLE ATROPHY 7 0.0006
484 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
485 FLUID OVERLOAD 8 0.0005
486 METASTASES TO BONE 9 0.0005
487 EXOSTOSIS 5 0.0005
488 PULMONARY EMBOLISM 52 0.0005
489 ABDOMINAL PAIN 127 0.0005
490 MYDRIASIS 7 0.0005
491 PRODUCT ADMINISTRATION ERROR 11 0.0005
492 SKIN DISCOLOURATION 25 0.0005
493 DENTAL CARIES 6 0.0005
494 FEEDING DISORDER 11 0.0005
495 TASTE DISORDER 11 0.0005
496 IRON DEFICIENCY ANAEMIA 5 0.0005
497 PRODUCT DISTRIBUTION ISSUE 5 0.0005
498 FEELING COLD 15 0.0005
499 PULMONARY MASS 8 0.0005
500 HEPATIC STEATOSIS 10 0.0005
501 BACTERIAL INFECTION 10 0.0005
502 APPENDICITIS 5 0.0005
503 SKIN INFECTION 6 0.0005
504 OCULAR DISCOMFORT 6 0.0005
505 BACK PAIN 124 0.0005
506 CHROMATURIA 12 0.0005
507 STATUS EPILEPTICUS 6 0.0005
508 SCAR 9 0.0005
509 CHOLECYSTECTOMY 6 0.0005
510 HAEMODYNAMIC INSTABILITY 4 0.0005
511 CHEST PAIN 97 0.0005
512 HYPERSOMNIA 15 0.0005
513 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
514 LIPASE INCREASED 4 0.0005
515 VOMITING 245 0.0005
516 MUSCLE TWITCHING 12 0.0005
517 CONCUSSION 4 0.0005
518 APHTHOUS ULCER 4 0.0005
519 POST PROCEDURAL HAEMORRHAGE 6 0.0005
520 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
521 HEART RATE DECREASED 18 0.0005
522 CARDIOVASCULAR DISORDER 13 0.0005
523 SKIN FISSURES 10 0.0005
524 DEPRESSED MOOD 27 0.0005
525 CORONARY ARTERY OCCLUSION 7 0.0005
526 RENAL TUBULAR NECROSIS 5 0.0005
527 ACUTE MYOCARDIAL INFARCTION 15 0.0005
528 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
529 BACTERAEMIA 6 0.0005
530 PRODUCT PRESCRIBING ISSUE 11 0.0005
531 HAEMATOCRIT DECREASED 10 0.0005
532 URINARY TRACT INFECTION 86 0.0005
533 MYOCLONUS 6 0.0005
534 GINGIVAL PAIN 4 0.0005
535 INFLUENZA 56 0.0005
536 ATRIAL FLUTTER 4 0.0005
537 WEIGHT DECREASED 139 0.0005
538 DEVICE OCCLUSION 7 0.0005
539 NIGHT SWEATS 16 0.0005
540 RENAL FAILURE ACUTE 21 0.0005
541 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
542 BONE MARROW FAILURE 10 0.0005
543 FOETAL EXPOSURE DURING PREGNANCY 40 0.0005
544 EYELID PTOSIS 5 0.0005
545 LOSS OF CONSCIOUSNESS 63 0.0005
546 PARALYSIS 7 0.0005
547 DYSURIA 18 0.0005
548 MUSCLE SPASTICITY 6 0.0005
549 CARDIOMEGALY 6 0.0005
550 ANAEMIA 93 0.0005
551 ESCHERICHIA INFECTION 4 0.0005
552 INJECTION SITE EXTRAVASATION 6 0.0005
553 LIMB DISCOMFORT 15 0.0005
554 PRODUCT AVAILABILITY ISSUE 11 0.0005
555 NECK PAIN 27 0.0005
556 AGEUSIA 12 0.0005
557 FUNGAL INFECTION 16 0.0005
558 TINNITUS 22 0.0005
559 DYSPHONIA 28 0.0005
560 BRONCHITIS 35 0.0005
561 RESPIRATORY ARREST 13 0.0005
562 HYPOPHAGIA 12 0.0005
563 LUNG DISORDER 23 0.0005
564 PROCEDURAL PAIN 13 0.0005
565 OEDEMA PERIPHERAL 57 0.0005
566 NASOPHARYNGITIS 86 0.0005
567 BREAST CANCER METASTATIC 5 0.0005
568 MUSCULOSKELETAL DISCOMFORT 8 0.0005
569 HEPATIC FAILURE 14 0.0005
570 HIATUS HERNIA 6 0.0005
571 LACTIC ACIDOSIS 15 0.0005
572 DIPLOPIA 12 0.0005
573 FAECES DISCOLOURED 10 0.0005
574 HAEMORRHAGE 48 0.0005
575 NEPHROLITHIASIS 21 0.0005
576 WOUND INFECTION 5 0.0005
577 BEDRIDDEN 6 0.0005
578 BLOOD CALCIUM INCREASED 4 0.0005
579 THROMBOCYTOPENIA 51 0.0005
580 GROIN PAIN 4 0.0005
581 LOCALISED INFECTION 11 0.0005
582 TENDONITIS 7 0.0005
583 TRANSAMINASES INCREASED 10 0.0004
584 NERVE INJURY 5 0.0004
585 URINARY RETENTION 15 0.0004
586 RASH MACULO-PAPULAR 10 0.0004
587 PREGNANCY 9 0.0004
588 FULL BLOOD COUNT DECREASED 9 0.0004
589 GASTROINTESTINAL INFECTION 4 0.0004
590 PRODUCT USE COMPLAINT 7 0.0004
591 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
592 OSTEOMYELITIS 8 0.0004
593 PNEUMONITIS 12 0.0004
594 NAUSEA 348 0.0004
595 BONE DISORDER 8 0.0004
596 HYPOTHYROIDISM 14 0.0004
597 SENSORY DISTURBANCE 7 0.0004
598 DECREASED APPETITE 101 0.0004
599 PERITONITIS 9 0.0004
600 SEIZURE 50 0.0004
601 PERICARDIAL EFFUSION 10 0.0004
602 HUNGER 6 0.0004
603 APHASIA 13 0.0004
604 WOUND 12 0.0004
605 STOMATITIS 26 0.0004
606 HYPERKALAEMIA 15 0.0004
607 SPLENOMEGALY 5 0.0004
608 DIZZINESS 212 0.0004
609 RETCHING 9 0.0004
610 ATAXIA 5 0.0004
611 MUCOSAL INFLAMMATION 11 0.0004
612 CATARACT 25 0.0004
613 MUSCLE RIGIDITY 5 0.0004
614 POLYNEUROPATHY 5 0.0004
615 ILLNESS 43 0.0004
616 IMPAIRED QUALITY OF LIFE 6 0.0004
617 CELLULITIS 21 0.0004
618 ANOSMIA 6 0.0004
619 HYPERTHYROIDISM 6 0.0004
620 HERNIA 8 0.0004
621 BURSITIS 5 0.0004
622 ADRENAL INSUFFICIENCY 5 0.0004
623 NOCTURIA 5 0.0004
624 PRESYNCOPE 10 0.0004
625 NEURALGIA 10 0.0004
626 OROPHARYNGEAL PAIN 38 0.0004
627 DISCOMFORT 25 0.0004
628 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
629 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
630 BODY TEMPERATURE DECREASED 4 0.0004
631 BLOOD PRESSURE INCREASED 62 0.0004
632 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
633 HEPATOTOXICITY 9 0.0004
634 DELIRIUM 14 0.0004
635 PHARYNGITIS 5 0.0004
636 COLON CANCER 6 0.0004
637 ILEUS 5 0.0004
638 HEPATIC FUNCTION ABNORMAL 15 0.0004
639 ASTHENIA 151 0.0004
640 ANXIETY 114 0.0004
641 OFF LABEL USE 350 0.0004
642 CARDIAC FAILURE 32 0.0004
643 INTESTINAL OBSTRUCTION 15 0.0004
644 TREMOR 66 0.0004
645 RECTAL HAEMORRHAGE 17 0.0004
646 RENAL IMPAIRMENT 33 0.0004
647 BODY TEMPERATURE INCREASED 8 0.0004
648 EYE PAIN 22 0.0004
649 DEVICE RELATED INFECTION 6 0.0004
650 HAEMOGLOBIN DECREASED 40 0.0004
651 MIGRAINE 37 0.0004
652 RED BLOOD CELL COUNT DECREASED 11 0.0004
653 THERAPY PARTIAL RESPONDER 6 0.0004
654 SWOLLEN TONGUE 12 0.0004
655 END STAGE RENAL DISEASE 7 0.0004
656 ABDOMINAL PAIN UPPER 79 0.0004
657 BRAIN FOG 6 0.0004
658 ACCIDENTAL OVERDOSE 14 0.0004
659 PAIN 235 0.0004
660 GASTRITIS 10 0.0004
661 LEUKOPENIA 19 0.0004
662 MOUTH ULCERATION 8 0.0004
663 TOOTH INFECTION 5 0.0004
664 VISION BLURRED 52 0.0004
665 THERAPY NON-RESPONDER 17 0.0004
666 NEEDLE ISSUE 11 0.0004
667 PERIPHERAL SWELLING 58 0.0004
668 ABSCESS 6 0.0004
669 BODY HEIGHT DECREASED 4 0.0004
670 QUALITY OF LIFE DECREASED 5 0.0004
671 PHOTOPHOBIA 7 0.0004
672 GENERAL PHYSICAL HEALTH DETERIORATION 43 0.0004
673 DEEP VEIN THROMBOSIS 24 0.0004
674 BACK DISORDER 6 0.0004
675 BLOOD URINE PRESENT 7 0.0004
676 INFLAMMATION 19 0.0004
677 NEUTROPHIL COUNT DECREASED 15 0.0004
678 LYMPHADENOPATHY 13 0.0004
679 SLEEP APNOEA SYNDROME 7 0.0004
680 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
681 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
682 LOWER LIMB FRACTURE 7 0.0004
683 ABDOMINAL DISTENSION 38 0.0004
684 OSTEONECROSIS OF JAW 9 0.0004
685 SPEECH DISORDER 19 0.0004
686 ERYTHEMA 74 0.0004
687 HYPERTENSIVE CRISIS 4 0.0004
688 HYPERTENSION 76 0.0004
689 PANCYTOPENIA 20 0.0004
690 EYE PRURITUS 12 0.0004
691 INTESTINAL PERFORATION 4 0.0004
692 PANCREATITIS ACUTE 8 0.0004
693 MALAISE 156 0.0004
694 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 64 0.0004
695 EYE INFECTION 4 0.0004
696 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
697 SWELLING 33 0.0004
698 NERVOUS SYSTEM DISORDER 11 0.0004
699 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
700 HAEMATURIA 12 0.0004
701 MICTURITION URGENCY 4 0.0003
702 HYPOACUSIS 15 0.0003
703 HEAD INJURY 11 0.0003
704 HAEMATOMA 9 0.0003
705 DISEASE PROGRESSION 41 0.0003
706 DYSPEPSIA 34 0.0003
707 CYSTITIS 11 0.0003
708 MENTAL DISORDER 15 0.0003
709 LIVER FUNCTION TEST ABNORMAL 10 0.0003
710 SEDATION 9 0.0003
711 RASH MACULAR 12 0.0003
712 MUSCULAR WEAKNESS 39 0.0003
713 DYSSTASIA 10 0.0003
714 PRODUCT PREPARATION ERROR 7 0.0003
715 AGITATION 25 0.0003
716 URTICARIA 57 0.0003
717 ABDOMINAL DISCOMFORT 57 0.0003
718 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
719 HYPERSENSITIVITY 63 0.0003
720 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
721 NEUTROPENIA 46 0.0003
722 SKIN HAEMORRHAGE 5 0.0003
723 DIARRHOEA 217 0.0003
724 POLLAKIURIA 14 0.0003
725 CHOLELITHIASIS 11 0.0003
726 GASTROOESOPHAGEAL REFLUX DISEASE 27 0.0003
727 ACCIDENT 4 0.0003
728 HYPERLIPIDAEMIA 4 0.0003
729 GOUT 6 0.0003
730 CONFUSIONAL STATE 54 0.0003
731 FALL 111 0.0003
732 PLASMA CELL MYELOMA 13 0.0003
733 MYELOSUPPRESSION 12 0.0003
734 HEART RATE INCREASED 33 0.0003
735 DIABETIC KETOACIDOSIS 8 0.0003
736 THROAT TIGHTNESS 9 0.0003
737 HOSPITALISATION 51 0.0003
738 NO ADVERSE EVENT 60 0.0003
739 ECONOMIC PROBLEM 5 0.0003
740 BLOOD COUNT ABNORMAL 5 0.0003
741 SKIN LESION 9 0.0003
742 INJURY 23 0.0003
743 DYSPHAGIA 31 0.0003
744 PRODUCT DOSE OMISSION ISSUE 96 0.0003
745 LIVER INJURY 8 0.0003
746 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
747 POOR QUALITY SLEEP 7 0.0003
748 CONJUNCTIVITIS 6 0.0003
749 ANKLE FRACTURE 5 0.0003
750 SWELLING FACE 21 0.0003
751 HEADACHE 202 0.0003
752 MIDDLE INSOMNIA 6 0.0003
753 BLISTER 18 0.0003
754 TOXICITY TO VARIOUS AGENTS 54 0.0003
755 ANGIOEDEMA 14 0.0003
756 CONSTIPATION 69 0.0003
757 ABDOMINAL PAIN LOWER 8 0.0003
758 PALPITATIONS 37 0.0003
759 HAEMATEMESIS 8 0.0003
760 COMA 15 0.0003
761 TOOTH DISORDER 7 0.0003
762 COVID-19 55 0.0003
763 GASTROINTESTINAL DISORDER 28 0.0003
764 GLAUCOMA 6 0.0003
765 INJECTION SITE INDURATION 4 0.0003
766 FATIGUE 239 0.0003
767 NERVOUSNESS 16 0.0003
768 MOBILITY DECREASED 22 0.0003
769 ECZEMA 16 0.0003
770 ALOPECIA 60 0.0003
771 SHOCK 7 0.0003
772 WEIGHT INCREASED 68 0.0003
773 IMMUNE SYSTEM DISORDER 4 0.0003
774 CHRONIC KIDNEY DISEASE 23 0.0003
775 CONTUSION 29 0.0003
776 UPPER LIMB FRACTURE 6 0.0003
777 EYE HAEMORRHAGE 4 0.0003
778 AGGRESSION 15 0.0003
779 GAIT INABILITY 10 0.0003
780 PRODUCT USE ISSUE 56 0.0003
781 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
782 VERTIGO 18 0.0003
783 OCULAR HYPERAEMIA 14 0.0003
784 RENAL FAILURE 39 0.0003
785 DRUG ADMINISTRATION ERROR 9 0.0003
786 LIVER DISORDER 13 0.0003
787 GINGIVAL BLEEDING 4 0.0003
788 EMOTIONAL DISORDER 9 0.0003
789 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
790 CONDITION AGGRAVATED 88 0.0003
791 INTERSTITIAL LUNG DISEASE 14 0.0003
792 DRUG-INDUCED LIVER INJURY 9 0.0003
793 ROAD TRAFFIC ACCIDENT 12 0.0003
794 LOCAL SWELLING 5 0.0003
795 CEREBRAL INFARCTION 7 0.0003
796 WHITE BLOOD CELL COUNT DECREASED 31 0.0003
797 THROMBOSIS 23 0.0003
798 CARPAL TUNNEL SYNDROME 4 0.0003
799 SOMNOLENCE 57 0.0003
800 IRRITABILITY 17 0.0003
801 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
802 GAIT DISTURBANCE 54 0.0003
803 EXTRAPYRAMIDAL DISORDER 7 0.0003
804 PLATELET COUNT DECREASED 30 0.0003
805 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
806 CONVULSION 16 0.0003
807 PAIN IN EXTREMITY 82 0.0003
808 PRURITUS GENERALISED 6 0.0003
809 HYPOKINESIA 4 0.0003
810 CRYING 10 0.0003
811 RESTLESS LEGS SYNDROME 5 0.0003
812 IMPAIRED HEALING 9 0.0003
813 EXPOSURE DURING PREGNANCY 17 0.0003
814 BONE PAIN 16 0.0003
815 DRUG RESISTANCE 7 0.0003
816 FEELING ABNORMAL 65 0.0003
817 PRURITUS 104 0.0003
818 SYNCOPE 27 0.0003
819 SKIN DISORDER 9 0.0003
820 MEMORY IMPAIRMENT 37 0.0003
821 THINKING ABNORMAL 5 0.0003
822 GLOSSODYNIA 6 0.0003
823 ORAL PAIN 6 0.0003
824 DEAFNESS 7 0.0003
825 HAEMORRHAGE INTRACRANIAL 4 0.0003
826 OSTEOPOROSIS 11 0.0003
827 JOINT STIFFNESS 7 0.0003
828 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
829 ANGER 9 0.0003
830 PANCREATITIS 14 0.0003
831 DRUG INTERACTION 42 0.0003
832 MYALGIA 45 0.0003
833 CORONARY ARTERY DISEASE 8 0.0003
834 COLITIS 10 0.0003
835 FOOT FRACTURE 5 0.0003
836 FEAR 7 0.0003
837 RASH PRURITIC 14 0.0003
838 RENAL DISORDER 12 0.0003
839 BLOOD CHOLESTEROL INCREASED 12 0.0003
840 BURNING SENSATION 18 0.0003
841 NEUROPATHY PERIPHERAL 24 0.0003
842 RASH ERYTHEMATOUS 12 0.0003
843 HEPATIC ENZYME INCREASED 17 0.0002
844 CARDIAC FAILURE CONGESTIVE 20 0.0002
845 INSOMNIA 66 0.0002
846 ARTHRALGIA 103 0.0002
847 DRY MOUTH 20 0.0002
848 HERPES ZOSTER 14 0.0002
849 EYE DISORDER 8 0.0002
850 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
851 RIB FRACTURE 5 0.0002
852 ABASIA 6 0.0002
853 EYE SWELLING 9 0.0002
854 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
855 SLEEP DISORDER 17 0.0002
856 CYTOMEGALOVIRUS INFECTION 4 0.0002
857 UNEVALUABLE EVENT 18 0.0002
858 HALLUCINATION, VISUAL 5 0.0002
859 SKIN ULCER 6 0.0002
860 THERAPEUTIC RESPONSE DECREASED 14 0.0002
861 DEVICE DEFECTIVE 4 0.0002
862 DEVICE DISLOCATION 10 0.0002
863 DRUG INEFFECTIVE 301 0.0002
864 MUSCULOSKELETAL STIFFNESS 20 0.0002
865 DEVICE MALFUNCTION 16 0.0002
866 METASTASES TO LIVER 4 0.0002
867 APPLICATION SITE PAIN 5 0.0002
868 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
869 EYE IRRITATION 13 0.0002
870 HOT FLUSH 17 0.0002
871 ISCHAEMIC STROKE 4 0.0002
872 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
873 EXTRA DOSE ADMINISTERED 9 0.0002
874 DRY EYE 11 0.0002
875 BALANCE DISORDER 19 0.0002
876 HAEMATOCHEZIA 12 0.0002
877 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
878 RHABDOMYOLYSIS 9 0.0002
879 JOINT SWELLING 26 0.0002
880 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
881 SUICIDE ATTEMPT 13 0.0002
882 MUSCULOSKELETAL PAIN 11 0.0002
883 PRODUCT USE IN UNAPPROVED INDICATION 52 0.0002
884 VISUAL IMPAIRMENT 26 0.0002
885 TYPE 2 DIABETES MELLITUS 7 0.0002
886 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
887 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
888 RASH 89 0.0002
889 INJECTION SITE REACTION 14 0.0002
890 DISABILITY 4 0.0002
891 BLOOD PRESSURE ABNORMAL 4 0.0002
892 HALLUCINATION 15 0.0002
893 LACRIMATION INCREASED 6 0.0002
894 SKIN IRRITATION 9 0.0002
895 THERAPY INTERRUPTED 14 0.0002
896 COGNITIVE DISORDER 9 0.0002
897 SKIN EXFOLIATION 16 0.0002
898 DEVICE ISSUE 17 0.0002
899 IRRITABLE BOWEL SYNDROME 4 0.0002
900 JAUNDICE 5 0.0002
901 INJECTION SITE ERYTHEMA 23 0.0002
902 DIABETES MELLITUS 14 0.0002
903 MOOD ALTERED 5 0.0002
904 VISUAL ACUITY REDUCED 6 0.0002
905 LIP SWELLING 6 0.0002
906 ARTHROPATHY 10 0.0002
907 INJECTION SITE PRURITUS 12 0.0002
908 HEART RATE IRREGULAR 4 0.0002
909 INJECTION SITE PAIN 54 0.0002
910 INCORRECT DOSE ADMINISTERED 40 0.0002
911 ABORTION SPONTANEOUS 7 0.0002
912 CEREBRAL HAEMORRHAGE 6 0.0002
913 OVERDOSE 36 0.0002
914 BLOOD PRESSURE FLUCTUATION 4 0.0002
915 CEREBROVASCULAR ACCIDENT 28 0.0002
916 ARTHRITIS 13 0.0002
917 HYPOGLYCAEMIA 8 0.0002
918 PANIC ATTACK 6 0.0002
919 TREATMENT NONCOMPLIANCE 9 0.0002
920 EPILEPSY 5 0.0002
921 INJECTION SITE URTICARIA 4 0.0002
922 FEMUR FRACTURE 5 0.0002
923 DEVICE LEAKAGE 7 0.0002
924 CARDIAC DISORDER 15 0.0002
925 BLOOD GLUCOSE INCREASED 30 0.0002
926 INFLUENZA LIKE ILLNESS 13 0.0002
927 DRY SKIN 21 0.0002
928 EMOTIONAL DISTRESS 19 0.0002
929 MOOD SWINGS 5 0.0002
930 COLITIS ULCERATIVE 7 0.0002
931 HEPATITIS 4 0.0002
932 INTENTIONAL OVERDOSE 10 0.0002
933 HIP FRACTURE 5 0.0002
934 EXPOSURE VIA SKIN CONTACT 4 0.0002
935 OSTEONECROSIS 5 0.0002
936 MENSTRUATION IRREGULAR 4 0.0001
937 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
938 TREATMENT FAILURE 12 0.0001
939 DIVERTICULITIS 4 0.0001
940 MEDICATION ERROR 8 0.0001
941 NEOPLASM PROGRESSION 5 0.0001
942 INTENTIONAL DOSE OMISSION 4 0.0001
943 INJECTION SITE BRUISING 11 0.0001
944 DRUG EFFECT INCOMPLETE 5 0.0001
945 SURGERY 8 0.0001
946 DRUG INTOLERANCE 13 0.0001
947 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
948 INJECTION SITE RASH 4 0.0001
949 DRUG EFFECT DECREASED 7 0.0001
950 BONE DENSITY DECREASED 4 0.0001
951 DEPRESSION 29 0.0001
952 ABNORMAL BEHAVIOUR 5 0.0001
953 SKIN BURNING SENSATION 9 0.0001
954 BLOOD GLUCOSE DECREASED 6 0.0001
955 DEVICE BREAKAGE 5 0.0001
956 MYOCARDIAL INFARCTION 21 0.0001
957 NEOPLASM MALIGNANT 8 0.0001
958 THERAPY CESSATION 6 0.0001
959 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
960 ILL-DEFINED DISORDER 7 0.0001
961 INTENTIONAL PRODUCT MISUSE 10 0.0001
962 DEATH 95 0.0001
963 INJECTION SITE MASS 4 0.0001
964 DRUG ABUSE 9 0.0001
965 AMNESIA 7 0.0001
966 PSORIASIS 14 0.0001
967 MULTIPLE SCLEROSIS 5 0.0001
968 INJECTION SITE SWELLING 8 0.0001
969 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
970 BLINDNESS 4 0.0001
971 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
972 UNDERDOSE 7 0.0001
973 DISTURBANCE IN ATTENTION 5 0.0001
974 PRODUCT STORAGE ERROR 8 0.0001
975 ADVERSE DRUG REACTION 8 0.0001
976 INJECTION SITE HAEMORRHAGE 7 0.0001
977 ADVERSE EVENT 8 0.0001
978 DRUG DOSE OMISSION 14 0.0001
979 DISEASE RECURRENCE 4 0.0001
980 DRUG WITHDRAWAL SYNDROME 7 0.0001
981 RHEUMATOID ARTHRITIS 9 0.0001
982 ACNE 6 0.0001
983 DERMATITIS ATOPIC 4 0.0001
984 PROSTATE CANCER 6 0.0001
985 PRODUCT QUALITY ISSUE 9 0.0001
986 SUICIDAL IDEATION 5 0.0001
987 DRUG DOSE OMISSION BY DEVICE 4 0.0001
988 DRUG DEPENDENCE 7 0.0000
989 BREAST CANCER 4 0.0000